secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seres Therapeutics, Inc. (MCRB)
CIK:        0001609809
Form:       8-K
Filed at:   2023-06-28T23:59:59+00:00
Accession:  0001193125-23-176795
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seres increases authorized shares to 240M and updates on Oaktree credit facility tranche conditions
--------------------------------------------------------------------------------

- Stockholders approved increase in authorized common shares from 200M to 240M; Certificate of Amendment filed June 27, 2023.
- Company posted updated corporate presentation disclosing funding conditions for Tranche B and Tranche C of Oaktree Credit Facility.
- Management states funding requirements for Tranche B and Tranche C are achievable.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609809/000119312523176795/0001193125-23-176795-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609809/000119312523176795/d506361d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-176795

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer